Significantly, targeting STAT3 induced anti‐HCC immune memory and accumulation of the important antitumour effector CD8+ T cells in tumour tissues, which expressed low levels of checkpoint molecules such as LAG‐3 and PD‐1. This evidence concerns the gene CD8A and hepatocellular carcinoma.